Fructose-1,6-bisphosphatase (EC 3.1.3.11) activity was determined by monitoring the formation of fructose-6-phosphate (F6P) using a coupled spectrophotometric assay. The specific activity of rFBP1 was determined in 1 ml reactions containing 50 mM TES pH 7.4, 0.2 mM NADP+, 0.1 M KCl, 0.05 mM EDTA, 2 mM (NH4)2SO4, 2 mM MgCl2, 0.05 % (w/v) BSA, 2 mM 2-mercaptoethanol, 0.8 U/ml phosphoglucose isomerase and 0.5 U/ml glucose-6-phosphate dehydrogenase. Reactions were started by the addition of 35 μM F-1,6-P2 and A340 recorded in a Cary 100 spectrophotometer at 30°C. Reaction rates were calculated from the linear phase assuming ε(NADPH) = 6.22 mM-1.cm-1. 1 U is defined as 1 μmol F6P formed per min at 30°C. Where appropriate, 1 U/ml AMP deaminase (purified from chicken muscle using P11 phosphocellulose essentially as described by Smiley4) was included to remove contaminating AMP from NADP+ as described by Han5. The activity ratio at pH 7.2/9.4 was determined under similar conditions in reactions buffered with 50 mM bis-tris propane at the appropriate pH. Other kinetic properties were determined in a 96 well format in non-binding black microplates (Greiner #655900), where the quantity of NADP+ was reduced to 0.15 mM and reactions were monitored by the increase in fluorescence (λex = 345 nm, λem = 465 nm) calibrated by the addition of 5 nmol F6P. Km(F-1,6-P2) was determined at 2 mM Mg2+ and fitted to equation 1:
Where: V = initial velocity, Vm = maximum velocity, [S] = F-1,6-P2 conc., Km = Michaelis constant for S, Ks = apparent substrate inhibition constant and b = factor determining maximum activity at high [S].
Km(Mg2+) was determined at 35 μM F-1,6-P2 and fitted to equation 2:
Where: V = initial velocity, Vm = maximum velocity, [S] = Mg2+ conc., Km = Michaelis constant for S and h = hill coefficient.
IC50 for inhibitory compounds was determined at 2 mM Mg2+, 35 μM F-1,6-P2 and fitted to equation 3:
Where: V = initial velocity, V0 = maximum velocity in the absence of inhibitor, I = conc. inhibitor, I0.5 = conc. of inhibitor that gives 50 % inhibition and h = hill coefficient.
Stock solutions of F-1,6-P2 were standardized by enzymatic assay in reactions containing 50 mM imidazole pH 7, 0.15 mM NADH, 0.02 U/ml aldolase, 1.2 U/ml triosephosphate isomerase and 0.16 U/ml glycerol-3-phosphate dehydrogenase. Stock solutions of AMP, 5’-inosine monophosphate (IMP) and 5’-AICAR monophosphate (ZMP) were prepared in 20 mM TES pH 7.4, neutralized with NaOH and standardized by UV absorbance in 0.1 M phosphate pH 7 at A259 (εAMP = 15.4 mM-1.cm-1), A249 (εIMP = 12 mM-1.cm-1) and A265 (εZMP = 12.5 mM-1.cm-1) respectively. F-2,6-P2 is difficult to obtain commercially and the crude product available from Toronto Research Chemicals was solubilized in 10 mM NaOH and standardized in reactions containing 50 mM HEPES pH 7.1, 5 mM MgCl2, 0.1 mM EDTA, 0.15 mM NADP+ by sequential addition of 0.1 U/ml glucose-6-phosphate dehydrogenase, 0.2 U/ml phosphoglucose isomerase and 0.25 U/ml GST-FBPase-2 P251-N440 while recording the increase in A340.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.